On the move to stimulate cell plasticity in the substantia nigra in Parkinson's disease.
Brundin
Patrik
P
Neuronal Survival Unit, BMC A10, Department of Experimental Medical Science, Wallenberg Neuroscience Center, 22184 Lund, Sweden. patrik.brundin@med.lu.se
Angela Cenci
M
M
Wieloch
Tadeusz
T
D000818:Animals; D009043:Motor Activity / Q000187:drug effects / Q000502:physiology*; D009473:Neuronal Plasticity / Q000187:drug effects / Q000502:physiology*; D016627:Oxidopamine / Q000633:toxicity; D010302:Parkinson Disease, Secondary / Q000139:chemically induced / Q000503:physiopathology*; D051381:Rats; D013378:Substantia Nigra / Q000187:drug effects / Q000503:physiopathology*
D016627:Oxidopamine